Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Curious

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Mar 21, 2023 4:43pm

170 Views

Post# 35352224

RE:RE:RE:Curious

Q4 reports tie into year end and the annual reports so yes they tend to come out later for most companies.

I assume that if Roger were to take over it would be after the auditors had a look at the 2022 results and signed off on them, but what do I know?

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment